Clinical utility of family history of depression for prognosis of adolescent depression severity and duration assessed with predictive modeling.

Depression adolescence family history longitudinal studies

Journal

Journal of child psychology and psychiatry, and allied disciplines
ISSN: 1469-7610
Titre abrégé: J Child Psychol Psychiatry
Pays: England
ID NLM: 0375361

Informations de publication

Date de publication:
08 2022
Historique:
accepted: 21 10 2021
pubmed: 1 12 2021
medline: 23 7 2022
entrez: 30 11 2021
Statut: ppublish

Résumé

Family history of depression (FHD) is a known risk factor for the new onset of depression. However, it is unclear if FHD is clinically useful for prognosis in adolescents with current, ongoing, or past depression. This preregistered study uses a longitudinal, multi-informant design to examine whether a child's FHD adds information about future depressive episodes and depression severity applying state-of-the-art predictive out-of-sample methodology. We examined data in adolescents with current or past depression (age 11-17 years) from the National Institute of Mental Health Characterization and Treatment of Adolescent Depression (CAT-D) study. We asked whether a history of depression in a first-degree relative was predictive of depressive episode duration (72 participants) and future depressive symptom severity in probands (129 participants, 1,439 total assessments). Family history of depression, while statistically associated with time spent depressed, did not improve predictions of time spent depressed, nor did it improve models of change in depression severity measured by self- or parent-report. Family history of depression does not improve the prediction of the course of depression in adolescents already diagnosed with depression. The difference between statistical association and predictive models highlights the importance of assessing predictive performance when evaluating questions of clinical utility.

Sections du résumé

BACKGROUND
Family history of depression (FHD) is a known risk factor for the new onset of depression. However, it is unclear if FHD is clinically useful for prognosis in adolescents with current, ongoing, or past depression. This preregistered study uses a longitudinal, multi-informant design to examine whether a child's FHD adds information about future depressive episodes and depression severity applying state-of-the-art predictive out-of-sample methodology.
METHODS
We examined data in adolescents with current or past depression (age 11-17 years) from the National Institute of Mental Health Characterization and Treatment of Adolescent Depression (CAT-D) study. We asked whether a history of depression in a first-degree relative was predictive of depressive episode duration (72 participants) and future depressive symptom severity in probands (129 participants, 1,439 total assessments).
RESULTS
Family history of depression, while statistically associated with time spent depressed, did not improve predictions of time spent depressed, nor did it improve models of change in depression severity measured by self- or parent-report.
CONCLUSIONS
Family history of depression does not improve the prediction of the course of depression in adolescents already diagnosed with depression. The difference between statistical association and predictive models highlights the importance of assessing predictive performance when evaluating questions of clinical utility.

Identifiants

pubmed: 34847615
doi: 10.1111/jcpp.13547
pmc: PMC9541414
doi:

Banques de données

ClinicalTrials.gov
['NCT03388606']

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

939-947

Subventions

Organisme : Intramural NIH HHS
ID : ZIA MH002957
Pays : United States

Informations de copyright

Published 2021. This article is a U.S. Government work and is in the public domain in the USA. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.

Références

Psychol Med. 2018 Jul;48(10):1685-1693
pubmed: 29173194
Arch Gen Psychiatry. 2009 Jul;66(7):738-47
pubmed: 19581565
Psychol Rev. 2019 Nov;126(6):791-816
pubmed: 31414874
J Affect Disord. 1999 Oct;55(2-3):149-57
pubmed: 10628884
Int J Clin Health Psychol. 2016 Sep-Dec;16(3):221-229
pubmed: 30487865
J Affect Disord. 2013 May;147(1-3):225-31
pubmed: 23218899
Biol Psychiatry. 2008 Feb 15;63(4):406-14
pubmed: 17698041
J Affect Disord. 2012 May;138(3):259-67
pubmed: 22370067
Br J Psychiatry. 1994 Jul;165(1):66-72
pubmed: 7953060
J Abnorm Psychol. 2002 Feb;111(1):98-106
pubmed: 11866183
J Psychiatr Res. 2007 Apr-Jun;41(3-4):214-21
pubmed: 16690084
Can J Psychiatry. 2010 Oct;55(10):669-76
pubmed: 20964946
JAMA Psychiatry. 2020 May 1;77(5):534-540
pubmed: 31774490
Soc Psychiatry Psychiatr Epidemiol. 2009 Dec;44(12):1067-74
pubmed: 19319457
Int J Methods Psychiatr Res. 2018 Sep;27(3):e1610
pubmed: 29465165
Psychol Med. 2008 May;38(5):641-9
pubmed: 18272011
J Am Acad Child Adolesc Psychiatry. 2019 Dec;58(12):1157-1164
pubmed: 30825497
J Child Psychol Psychiatry. 2006 Dec;47(12):1292-8
pubmed: 17176384
J Psychiatr Res. 2014 Feb;49:90-5
pubmed: 24308926
J Affect Disord. 2016 Jul 1;198:15-22
pubmed: 26998792
Arch Gen Psychiatry. 1997 Jul;54(7):613-23
pubmed: 9236545
J Affect Disord. 2015 Jul 15;180:52-61
pubmed: 25881281
J Clin Psychiatry. 2009 Feb;70(2):185-95
pubmed: 19192454
J Am Acad Child Adolesc Psychiatry. 1996 Nov;35(11):1427-39
pubmed: 8936909
J Affect Disord. 2011 Mar;129(1-3):1-13
pubmed: 20488546

Auteurs

Lisa S Gorham (LS)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Neda Sadeghi (N)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Lillian Eisner (L)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Jeremy Taigman (J)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Katherine Haynes (K)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Karen Qi (K)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Christopher C Camp (CC)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Payton Fors (P)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Diana Rodriguez (D)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Jerry McGuire (J)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Erin Garth (E)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Chana Engel (C)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Mollie Davis (M)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Kenneth Towbin (K)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Argyris Stringaris (A)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Dylan M Nielson (DM)

Section of Clinical and Computational Psychiatry, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH